• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

CMAJ CONTROVERSY, AGAIN

By Jesse Staniforth
01/11/2020 09:50 AM GMT-0700
FacebookTweetPin

The Canadian Medical Association Journal waded yet again into canna-controversy with another alarmist opinion commentary about "health considerations" related to the legalization of edibles.CMAJ

  • Kamploops, BC ER physician Ian Mitchell immediately noted the report repeated the urban myth of cannabis being tainted with narcotics or opioids, retorting "there has NEVER been a confirmed case of cannabis contaminated with narcotics. This is a complete myth that . . .

    Log in or become a WeedWeek Member to read this article.

Share:
FacebookTweetPin
Filed Under:
Medical Marijuana

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: 2025 Wrap-Up & 2026 Outlook

Duration Broadcast Jan 22
Speakers Elisabeth Stahura, Alex Halperin

Watch Now

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Medical Marijuana Articles
lawmakers
Gavin Newsom

Newsbrief: Newsom’s MED bill veto sparks anger

The Promise of Ketamine as a Rapid-Acting Antidepressant
Sponsored

The Promise of Ketamine as a Rapid-Acting Antidepressant

Former TMS CEO joins Beyond Marketing as Medical and Education Director
Sponsored

Former TMS CEO joins Beyond Marketing as Medical and Education Director

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved